A citation-based method for searching scientific literature

Ludivine Dion, Isis Carton, Sylvie Jaillard, Krystel Nyangoh Timoh, Sébastien Henno, Hugo Sardain, Fabrice Foucher, Jean Levêque, Thibault de la Motte Rouge, Susie Brousse, Vincent Lavoué. J Clin Med 2020
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.
Madhusoodanan Mottamal, Shilong Zheng, Tien L Huang, Guangdi Wang. Molecules 2015
387
25

ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation.
Ueihuei Peng, Zhihao Wang, Sa Pei, Yunchao Ou, Pengchao Hu, Wanhong Liu, Jiquan Song. Oncol Rep 2017
8
25

Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.
Brian J North, Ingrid Almeciga-Pinto, David Tamang, Min Yang, Simon S Jones, Steven N Quayle. PLoS One 2017
25
25

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.
Loredana Santo, Teru Hideshima, Andrew L Kung, Jen-Chieh Tseng, David Tamang, Min Yang, Matthew Jarpe, John H van Duzer, Ralph Mazitschek, Walter C Ogier,[...]. Blood 2012
399
25

How Taxol/paclitaxel kills cancer cells.
Beth A Weaver. Mol Biol Cell 2014
435
25

HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis.
Hyun-Wook Ryu, Dong-Hee Shin, Dong Hoon Lee, Junjeong Choi, Gyoonhee Han, Kang Young Lee, So Hee Kwon. Cancer Lett 2017
38
25


Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.
Katrina J Falkenberg, Ricky W Johnstone. Nat Rev Drug Discov 2014
889
25

Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models.
Pengyu Huang, Ingrid Almeciga-Pinto, Matthew Jarpe, John H van Duzer, Ralph Mazitschek, Min Yang, Simon S Jones, Steven N Quayle. Oncotarget 2017
49
25

Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells.
Cristina Corno, Noemi Arrighetti, Emilio Ciusani, Elisabetta Corna, Nives Carenini, Nadia Zaffaroni, Laura Gatti, Paola Perego. Front Cell Dev Biol 2020
2
50


A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma.
Go Woon Kim, Jung Yoo, Hye-Rim Won, Soo-Keun Yeon, Sang Woo Lee, Dong Hoon Lee, Yu Hyun Jeon, So Hee Kwon. Leuk Res 2020
4
25

Ovarian cancer.
Gordon C Jayson, Elise C Kohn, Henry C Kitchener, Jonathan A Ledermann. Lancet 2014
937
25

Mechanisms of Taxol resistance related to microtubules.
George A Orr, Pascal Verdier-Pinard, Hayley McDaid, Susan Band Horwitz. Oncogene 2003
490
25

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.
Andrew J Yee, William I Bensinger, Jeffrey G Supko, Peter M Voorhees, Jesus G Berdeja, Paul G Richardson, Edward N Libby, Ellen E Wallace, Nicole E Birrer, Jill N Burke,[...]. Lancet Oncol 2016
110
25


HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma.
Hye-Rim Won, Dong Hoon Lee, Soo-Keun Yeon, Hyun-Wook Ryu, Go Woon Kim, So Hee Kwon. Int J Oncol 2019
5
25

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, Laura Saucedo-Cuevas, Patricia Villagrasa, Eva Murga-Penas, Steven N Quayle, Min Yang, Veronica Castro, David Llobet-Navas,[...]. Breast Cancer Res 2015
27
25

Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.
Jinlin Cao, Wang Lv, Luming Wang, Jinming Xu, Ping Yuan, Sha Huang, Zhehao He, Jian Hu. Cell Death Dis 2018
33
25

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Robert L Coleman, Mark F Brady, Thomas J Herzog, Paul Sabbatini, Deborah K Armstrong, Joan L Walker, Byoung-Gie Kim, Keiichi Fujiwara, Krishnansu S Tewari, David M O'Malley,[...]. Lancet Oncol 2017
234
25

Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair.
Go Woon Kim, Dong Hoon Lee, Soo-Keun Yeon, Yu Hyun Jeon, Jung Yoo, Sang Woo Lee, So Hee Kwon. Anticancer Res 2019
10
25

Therapeutic effect of bevacizumab combined with paclitaxel and carboplatin on recurrent ovarian cancer.
Jianglin Cong, Riming Liu, Jianqing Hou, Xiuli Wang, Haiyang Jiang, Jing Wang. J BUON 2019
3
33

p53 Acetylation: Regulation and Consequences.
Sara M Reed, Dawn E Quelle. Cancers (Basel) 2014
167
25

Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling.
Shun Li, Xiao Liu, Xiangrong Chen, Liu Zhang, Xiangyu Wang. Tumour Biol 2015
26
25


Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma.
Jennifer E Amengual, Paul Johannet, Maximilian Lombardo, Kelly Zullo, Daniela Hoehn, Govind Bhagat, Luigi Scotto, Xavier Jirau-Serrano, Dejan Radeski, Jennifer Heinen,[...]. Clin Cancer Res 2015
49
25

Combination of ACY-241 and JQ1 Synergistically Suppresses Metastasis of HNSCC via Regulation of MMP-2 and MMP-9.
Ha Young Cho, Sang Wu Lee, Yu Hyun Jeon, Dong Hoon Lee, Go Woon Kim, Jung Yoo, So Yeon Kim, So Hee Kwon. Int J Mol Sci 2020
3
33

Promotion of microtubule assembly in vitro by taxol.
P B Schiff, J Fant, S B Horwitz. Nature 1979
25

Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.
Valentina Zuco, Michelandrea De Cesare, Raffaella Cincinelli, Raffaella Nannei, Claudio Pisano, Nadia Zaffaroni, Franco Zunino. PLoS One 2011
40
25

The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
Dong Hoon Lee, Hye-Rim Won, Hyun-Wook Ryu, Jung Min Han, So Hee Kwon. Int J Oncol 2018
13
25

A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells.
Hye-Rim Won, Hyun-Wook Ryu, Dong-Hee Shin, Soo-Keun Yeon, Dong Hoon Lee, So Hee Kwon. Mol Carcinog 2018
14
25

Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.
Kiminori Kanno, Shoji Kanno, Hiroyuki Nitta, Noriyuki Uesugi, Tamostu Sugai, Tomoyuki Masuda, Go Wakabayashi, Chihaya Maesawa. Oncol Rep 2012
52
25


ARID1A-mutated ovarian cancers depend on HDAC6 activity.
Benjamin G Bitler, Shuai Wu, Pyoung Hwa Park, Yang Hai, Katherine M Aird, Yemin Wang, Yali Zhai, Andrew V Kossenkov, Ana Vara-Ailor, Frank J Rauscher,[...]. Nat Cell Biol 2017
103
25

NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms.
Fan Yao, Mingjun Sun, Ming Dong, Feng Jing, Bo Chen, Huimian Xu, Shubao Wang. Am J Med Sci 2013
15
25

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
Karen McLean, Lijun Tan, Danielle E Bolland, Lan G Coffman, Luke F Peterson, Moshe Talpaz, Nouri Neamati, Ronald J Buckanovich. Oncogene 2019
28
25

Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis.
Genevieve Bouchard-Fortier, Maria C Cusimano, Rouhi Fazelzad, Katrina Sajewycz, Lin Lu, Osvaldo Espin-Garcia, Taymaa May, Antoine Bouchard-Fortier, Sarah E Ferguson. Gynecol Oncol 2020
6
25

The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro.
Ling Zhang, Jun Gao, Lei Li, Zhaoshen Li, Yiqi Du, Yanfang Gong. Mol Biol Rep 2011
21
25

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Neuronal pentraxins mediate synaptic refinement in the developing visual system.
Lisa Bjartmar, Andrew D Huberman, Erik M Ullian, René C Rentería, Xiaoqin Liu, Weifeng Xu, Jennifer Prezioso, Michael W Susman, David Stellwagen, Caleb C Stokes,[...]. J Neurosci 2006
128
25

Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Nidhi Singh, Sumaira Rashid, Safoora Rashid, Nihar Ranjan Dash, Surabhi Gupta, Anoop Saraya. J Cancer Res Clin Oncol 2020
12
25

Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Qi Yang, Rui Wang, Bo Wei, Chuangang Peng, Le Wang, Guozhang Hu, Daliang Kong, Chao Du. DNA Cell Biol 2019
4
25

Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools.
Garth Funston, Victoria Hardy, Gary Abel, Emma J Crosbie, Jon Emery, Willie Hamilton, Fiona M Walter. Cancers (Basel) 2020
2
50

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
S Han, C Zhang, Q Li, J Dong, Y Liu, Y Huang, T Jiang, A Wu. Br J Cancer 2014
165
25

Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture.
Ye Zhang, Bin Yang, Zhi Du, Ying-Tang Gao, Yi-Jun Wang, Xiang Jing, Tong Bai. Clin Biochem 2010
8
25


Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma.
Jinpeng Zhou, Yang Jiang, Junshuang Zhao, Haiying Zhang, Jinlong Fu, Peng Luo, Yanju Ma, Dan Zou, Huiling Gao, Jiangfeng Hu,[...]. Cell Oncol (Dordr) 2020
9
25

A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
Sudhanshu Shukla, Irene Rosita Pia Patric, Sivaarumugam Thinagararjan, Sujaya Srinivasan, Baisakhi Mondal, Alangar S Hegde, Bangalore A Chandramouli, Vani Santosh, Arimappamagan Arivazhagan, Kumaravel Somasundaram. Cancer Res 2013
51
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.